Serum Homocysteine Level Is a Predictor of Relapse and Prognosis in Patients With First-Attack Neuromyelitis Optica Spectrum Disorders

Background: Many patients with neuromyelitis optica spectrum disorders (NMOSD) experience the adverse consequences of relapse and disability aggravation. Thus, it is necessary to identify sensitive and reliable biomarkers for early prognosis. This study investigated whether serum homocysteine (Hcy)...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Neurol
Main Authors: Zhang, Jinwei, Li, Yanfei, Zhou, Yongyan, Zhao, Yi, Xie, Haojie, Duan, Ranran, Yao, Yaobing, Gong, Zhe, Teng, Junfang, Jia, Yanjie
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2021
Assuntos:
Neurology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8187771/
https://ncbi.nlm.nih.gov/pubmed/34122309
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2021.667651
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares